News tagged with drug manufacturers
Related topics: centers for disease control and prevention , food and drug administration , health officials , drug
Tainted drug death toll rises to 14 in US
The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.
Diseases, Conditions, Syndromes
Oct 11, 2012 |
not rated yet |
0
Mayo Clinic physicians ID reasons for high cost of cancer drugs, prescribe solutions
A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians ...
Cancer
Oct 01, 2012 |
5 / 5 (1) |
0
Bangladesh doctors urge Viagra production halt
Bangladeshi doctors Wednesday asked the government to halt permits for Viagra to be mass produced for the domestic market, fearing it could lead to the anti-impotence drug becoming available over the counter.
Medications
Sep 26, 2012 |
5 / 5 (1) |
0
Newly approved additives will be used to made surgically implanted devices safer, more successful
What began in the Dentistry lab of Professor Paul Santerre more than a decade ago is now Interface Biologics Inc. (IBI) - a privately-held company poised to transform the market for medical devices in the ...
Surgery
Sep 19, 2012 |
not rated yet |
0
Added benefit of Cannabis sativa for spasticity due to multiple sclerosis is not proven
An extract from the plant Cannabis sativa (trade name Sativex) was approved in May 2011 for patients suffering from moderate to severe spastic paralysis and muscle spasms due to multiple sclerosis (MS). In an early benefi ...
Medications
Sep 17, 2012 |
not rated yet |
0
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: ...
Medications
Aug 16, 2012 |
not rated yet |
0
COI declarations and off-label drug use
Conflict-of-interest statements made by physicians and scientists in their medical journal articles after they had been allegedly paid by pharmaceutical manufacturers as part of off-label marketing programs are often inadequate, ...
Other
Aug 07, 2012 |
not rated yet |
0
Collagenase for Dupuytren's contracture: Added benefit not proven
Collagenase extracted from Clostridium histolyticum (trade name: Xiapex) was approved in the beginning of 2011 for the treatment of people with Dupuytren's contracture. In an early benefit assessment pursuant to the "Act ...
Diseases, Conditions, Syndromes
Jul 12, 2012 |
not rated yet |
0
Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved
Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells.
Cancer
May 30, 2012 |
not rated yet |
0
|
New federal disclosure law may have little impact on drugs prescribed
A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.
Medications
May 29, 2012 |
not rated yet |
0
|
Indian expert panel to probe drugs regulator
India's Health Ministry said Friday it had set up an expert panel to review the operations of its drug regulatory agency, accused of colluding with pharmaceutical firms to approve drugs without trials.
Medications
May 11, 2012 |
not rated yet |
0
India probes charges of violations by drugs regulator
India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.
Medications
May 10, 2012 |
not rated yet |
0
India licenses generic copy of patented Bayer drug
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Medications
Mar 12, 2012 |
5 / 5 (4) |
0
3Qs: Analyzing why sudden drug shortages occur
Drug manufacturers and the Food and Drug Administration (FDA) scrambled earlier this month to address a sudden shortage of methotrexate, a 60-year-old drug that treats children with severe cases of leukemia ...
Medications
Feb 28, 2012 |
not rated yet |
0
India's global pharmacy role threatened by EU pact
(AP) -- Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted ...
Medications
Feb 10, 2012 |
not rated yet |
0
